For decades, cannabis has been used in the treatment of various ailments. While clinical research on cannabis as a remedy for dementia is limited, existing evidence suggests potential benefits for patients. Furthermore, clinical trials affirm the safety of cannabinoid-based treatments for individuals with dementia. Selecting the appropriate cannabis product for dementia poses a challenge due to the vast array of available varieties.
However, referencing scientific literature on cannabinoids and terpenes suggests that products with medium-high CBD and medium-low THC concentrations could serve a purpose.
Medical Research on Dementia and Cannabis
Randomized clinical trials, while offering a high standard of evidence, are known for their regulatory constraints, time intensiveness, and resource demands. Consequently, researchers and medical professionals often turn to cohort studies and case reports to evaluate the efficacy of therapeutic interventions. A number of such studies highlight cannabinoids as potentially effective treatments for dementia.
In 1997, a US-based group observed increased appetite and reduced disturbed behavior in Alzheimer’s patients treated with a THC-based medication, Dronabinol, for six weeks. Similar outcomes were later documented in two Alzheimer’s patients receiving a comparable dose for just 14 days.
In 2014, a cohort of 40 patients with various dementia types exhibited reduced agitation and aggression, along with improved restfulness, following a higher dose of synthetic THC than used in standard clinical trials.
By May 2019, a Geneva hospital found that a higher dose of oral cannabis extract containing THC and CBD was well-tolerated and significantly improved behavioral issues, muscle rigidity, and daily care in 10 female dementia patients.
However, based on a recent scientific review examining the application of cannabinoids for dementia symptoms, these initial findings show promise. The research included individuals with various forms of dementia, potentially obscuring significant effects. Additionally, relatively low THC doses, combined with other medications, adds complexity to the challenge of reaching definitive conclusions.
Using Cannabis For Dementia
Choosing the appropriate cannabis variety can be a challenge in itself due to the vast amount of options available. With thousands of distinct cannabis strains, each possessing a unique chemical profile, the decision-making process becomes intricate. Since much of the clinical research involves cannabinoid-based medications instead of whole plant products, discovering the ideal fit may involve some trial and error. Many patients encounter frustration as they navigate the journey of identifying the right product, dosage, and managing potential side effects.
Cannabis and Dementia in Maryland
If you are searching for medical marijuana options, we are here to help. Dispensary Works is a Southern Maryland marijuana dispensary committed to providing the best cannabis product to our patients and clients. Our highly trained staff is here to help you select the best cannabis for your particular needs. We are here to guide you as you uncover the world of marijuana. If you want to learn more about who we are and what we do, contact us today!
